Rush Medical Center Home Page Information for healthcare Professionals Rush University
FIND A DOCTOR
PATIENT & VISTOR SERVICES
HEALTH INFORMATION
CLINICAL SERVICES
EVENTS & CLASSES
RUSH NEWS ROOM
CLINICAL TRIALS
RESEARCH AT RUSH
NURSING AT RUSH
WORK AT RUSH
GIVING TO RUSH

Bookmark This Page
Clinical Trails at Rush Bridge Study: Bridging Anticoagulation
Clinical Trial Protocol ID
10061504

Clinical Trial Investigator Name
Stuart W. Rosenbush, MD, FACC

Clinical Trial Title

Bridge: Bridging Anticoagulation for Patients with Atrial Fibrillation
 



Clinical Trial Protocol Description

The Bridge study will determine whether a bridging blood thinner called dalteparin is helpful or harmful for people with atrial fibrillation who stop taking warfarin in preparation for surgery or another  procedure.



Clinical Trial Eligibility Criteria

You may be eligible for this study if you:

  • Are 18 years of age or older
  • Have chronic atrial fibrillation
  • Have been treated with Coumadin for at least three months

This is a partial list of eligibility and exclusion criteria. To inquire whether you are eligible for this study, please call the contact number provided. If you choose to inquire via email, please refer to the study title in your correspondence.





Contact Name Sherry Nelson
Contact Phone (312) 942-8144
Contact E-mail clinical_trials@rush.edu
Promotional Information

Clinical Trials Home
Cardiovascular Disease Trials
Bridge Study: Bridging Anticoagulation


Related Topics
   
Find a Doctor | Patient & Visitor Services | Health Information
Clinical Services | Events & Classes | Rush News Room | Clinical Trials
Research At Rush
Disclaimer | Privacy Statement | Site Map

© Rush University Medical Center, Chicago, Illinois